Nora Penzel

2 months ago | nature.com | Nora Penzel |Jean Addington |Celso Arango |Sylvain Bouix |Dylan Campbell |Eduardo Castro | +20 more

AbstractThe Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ) project assesses a large sample of individuals at clinical high-risk for developing psychosis (CHR) and community controls. Subjects are enrolled in 43 sites across 5 continents. The assessments include domains similar to those acquired in previous CHR studies along with novel domains that are collected longitudinally across a period of 2 years.